Author:
Odor Peter M.,Bampoe Sohail,Dushianthan Ahilanandan,Bennett-Guerrero Elliott,Cro Suzie,Gan Tong J.,Grocott Michael P. W.,James Michael F. M.,Mythen Michael G.,O’Malley Catherine M. N.,Roche Anthony M.,Rowan Kathy,Burdett Edward
Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. Bampoe S, Odor PM, Dushianthan A, Bennett-Guerrero E, Cro S, Gan TJ, et al. Perioperative administration of buffered versus non-buffered crystalloid intravenous fluid to improve outcomes following adult surgical procedures. Cochrane Database Syst Rev. 2017;21(9):CD004089.
2. Base EM, Standl T, Lassnigg A, Skhirtladze K, Jungheinrich C, Gayko D, et al. Efficacy and safety of hydroxyethyl starch 6% in a balanced electrolyte solution (Volulyte) during cardiac surgery. J Cardiothorac Vasc Anesth. 2011;25(3):407–14.
3. Calvo-Vecino JM, Ripollés-Melchor J, Mythen MG, Casans-Francés R, Balik A, Artacho JP, et al. Effect of goal-directed haemodynamic therapy on postoperative complications in low–moderate risk surgical patients: a multicentre randomised controlled trial (FEDORA trial). Br J Anaesth. 2018;120(4):734–44.
4. Chin J, Macachor J, Ong KC, Ong BC. A comparison of 5% dextrose in 0.9% normal saline versus non-dextrose- containing crystalloids as the initial intravenous replacement fluid in elective surgery. Anaesth Intensive Care. 2006;34(5):613–7.
5. Gan TJ, Bennett-Guerrero E, Phillips-Bute B, Wakeling H, Moskowitz DM, Olufolabi Y, et al. Hextend, a physiologically balanced plasma expander for large volume use in major surgery: a randomized phase III clinical trial. Anesth Analg. 1999;88(5):992–8.